The creation of a drug consists of a copious and complicated series of projects that are all intertwined.

Andy Mehrotra, CEO of Unipr, joins the Patient Empowerment Program to discuss how Unipr’s AI based cloud program, project, and portfolio management platforms allow organizations like n-Lorem to quickly analyze data to inform program management. Today, n-Lorem effectively manages more than 90 accepted patient programs thanks to help from Unipr. Discovering locations where productivity can be increased while maintaining quality in every step is critical to treating as many nano-rare patients as possible.  

• Andy’s upbringing among physicians and pharmaceutical entrepreneurs
• Traveling the world to launch HUMIRA
• Enduring the frigid Boston winters at MIT
• Inspiration to found Unipr
• How biotech and pharmaceutical organizations can use Unipr to increase efficiency
• The partnership between Unipr and n-Lorem
• Unipr’s focus areas: Increasing the probability of success, decreasing the operational costs, and decreasing the cycle time for drug development
• Why Andy wants to help n-Lorem

Andy Mehrotra grew up in India surrounded by medicine and patient stories. His father was a pharmaceutical entrepreneur that worked for Merck before starting his own pharmaceutical company. His mother is a practitioner of homeopathic medicine. Naturally, Andy was strongly influenced by medicine and understood the value of helping others from a very young age. Medicine was often a discussion around the dinner table and with family friends, many of which were doctors. In fact, more doctors surrounded Andy than family members.  

During Andy’s teenage years, he tagged along with his father to visit pharmaceutical manufacturing facilities where he saw a plethora of products and medicines firsthand. Andy knew that he wanted to get involved with pharmaceuticals. He trained to be a pharmacist and started his journey in the industry as a pharmaceutical sales representative. He progressively held leadership roles in product management, brand marketing, and general management. 

Andy eventually dove into the world of projects and programs when Abbott needed operational leadership for the multi-indication launch of their flagship product, Humira, in 50+ global markets. The experience of uniting the efforts of thousands of cross-functional professionals for the development and commercialization of a new medicine using software technology transformed Andy’s career. Andy joined the joint Health, Sciences, and Technology program at MIT and Harvard Medical School to concentrate full-time on understanding the intricacies of processes surrounding the journey of new medicines, from research labs to clinical trials and global commercial launches. 

Andy’s past experiences gave him a unique angle. Not only did he understand drug development, but he also was a master of the technologies behind it. That thought and skillset sparked the creation of Unipr, the culmination of Andy’s 25+ years of experience in the life science industry. Unipr is an AI-based project data lake and predictive intelligence platform to accelerate research, development, and commercialization workflows. Unipr integrates with in-use tools to unify data from projects in various functions, phases, and stages in one place to help leaders visualize the real-time impact of progress and problems across interrelated programs. Unipr gives business executives the predictive power to foresee the future impact of strategies, improve crosstalk among functional groups, and raise decision-making rigor and discipline across teams. 

n-Lorem uses Unipr to help manage the complicated process of bringing a drug from bench to bedside for nano-rare patients. 

Andy Mehrotra is the Founder and CEO of Unipr, and he holds an MBA from AGSM in UNSW, Australia, and a Master of Health, Sciences, and Technology from MIT and Harvard Medical School.

Unipr is an AI-based project data lake and predictive intelligence platform to accelerate research, development, and commercialization workflows. Unipr integrates with in-use tools to unify data from projects in various functions, phases, and stages in one place to help leaders visualize the real-time impact of progress and problems across interrelated programs. Unipr gives business executives the predictive power to foresee the future impact of strategies, improve the cross-talk among functional groups, and raise decision-making rigor and discipline across teams.

To learn more about Unipr, visit www.unipr.com 

We cannot do
this alone

We hope that you join us on this journey to discover, develop and provide individualized antisense medicines for free for life for nano-rare patients. The ultimate personalized medicine approach – for free, for life.